Healx
Healx identifies existing drugs that could treat rare diseases, offering a cost effective way to improve patient quality of life
- This event has passed.
BIO-Europe Spring
We’re looking forward to attending BIO-Europe. Will we see you there? If you’re attending and are interested in discussing opportunities for co-development of rare disease treatments or out-licensing your drug repurposing assets then we’d be delighted to arrange a time to talk.
During the conference you’ll be able to meet with the following team members:
- Dr Mark Youssef, MBA – Global Head of Business Development & Licensing
- Dr Bruce Bloom – Chief Collaboration Officer
- Eugenia Wachters, MBA – VP Commercial Portfolio Strategy
- Dr Clara Tang – Business Manager, Early Commercial Strategy
- Dr Hannah Thompson – Product Manager
Please get in touch with a member of our team via the partnering platform to schedule a meeting. For all other enquiries please click here to contact us. We look forward to seeing you there!